We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Updates Supply-Chain Guidance on Verifying Suspect Products
FDA Updates Supply-Chain Guidance on Verifying Suspect Products
In a revised draft guidance released yesterday, the FDA outlined its latest thinking on prescription drug supply-chain verification systems that companies will need to implement to comply with the Drug Supply Chain Security Act (DSCSA), which goes into effect in November 2023.